Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. more
Time Frame | AMGN | Sector | S&P500 |
---|---|---|---|
1-Week Return | -5.35% | -2.06% | -0.55% |
1-Month Return | -7.17% | -1.92% | 2.72% |
3-Month Return | -22.27% | -10.4% | 7.66% |
6-Month Return | -15.43% | -4.6% | 10.15% |
1-Year Return | -6.06% | 4.06% | 27.53% |
3-Year Return | 17.63% | 1.94% | 32.31% |
5-Year Return | 6.96% | 36.48% | 89.2% |
10-Year Return | 53.6% | 97.46% | 194.59% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 23.36B | 25.42B | 25.98B | 26.32B | 28.19B | [{"date":"2019-12-31","value":82.87,"profit":true},{"date":"2020-12-31","value":90.19,"profit":true},{"date":"2021-12-31","value":92.16,"profit":true},{"date":"2022-12-31","value":93.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 4.36B | 6.16B | 6.45B | 6.41B | 8.45B | [{"date":"2019-12-31","value":51.54,"profit":true},{"date":"2020-12-31","value":72.88,"profit":true},{"date":"2021-12-31","value":76.37,"profit":true},{"date":"2022-12-31","value":75.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 19.01B | 19.27B | 19.52B | 19.92B | 19.74B | [{"date":"2019-12-31","value":95.43,"profit":true},{"date":"2020-12-31","value":96.73,"profit":true},{"date":"2021-12-31","value":98.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.11,"profit":true}] |
Gross Margin | 81.35% | 75.77% | 75.16% | 75.66% | 70.02% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":93.14,"profit":true},{"date":"2021-12-31","value":92.38,"profit":true},{"date":"2022-12-31","value":93.01,"profit":true},{"date":"2023-12-31","value":86.07,"profit":true}] |
Operating Expenses | 9.33B | 10.13B | 10.38B | 10.35B | 11.84B | [{"date":"2019-12-31","value":78.8,"profit":true},{"date":"2020-12-31","value":85.51,"profit":true},{"date":"2021-12-31","value":87.66,"profit":true},{"date":"2022-12-31","value":87.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 9.67B | 5.79B | 6.00B | 5.33B | 7.90B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":59.89,"profit":true},{"date":"2021-12-31","value":62.07,"profit":true},{"date":"2022-12-31","value":55.15,"profit":true},{"date":"2023-12-31","value":81.63,"profit":true}] |
Total Non-Operating Income/Expense | (1.07B) | (2.01B) | (501.00M) | 605.00M | (2.51B) | [{"date":"2019-12-31","value":-177.19,"profit":false},{"date":"2020-12-31","value":-332.56,"profit":false},{"date":"2021-12-31","value":-82.81,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-415.04,"profit":false}] |
Pre-Tax Income | 9.14B | 8.13B | 6.70B | 7.35B | 7.86B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":89,"profit":true},{"date":"2021-12-31","value":73.33,"profit":true},{"date":"2022-12-31","value":80.39,"profit":true},{"date":"2023-12-31","value":85.96,"profit":true}] |
Income Taxes | 1.30B | 869.00M | 808.00M | 794.00M | 1.14B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":67.05,"profit":true},{"date":"2021-12-31","value":62.35,"profit":true},{"date":"2022-12-31","value":61.27,"profit":true},{"date":"2023-12-31","value":87.81,"profit":true}] |
Income After Taxes | 7.84B | 7.26B | 5.89B | 6.55B | 6.72B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.63,"profit":true},{"date":"2021-12-31","value":75.15,"profit":true},{"date":"2022-12-31","value":83.55,"profit":true},{"date":"2023-12-31","value":85.65,"profit":true}] |
Income From Continuous Operations | 7.84B | 7.26B | 5.89B | 6.55B | 7.57B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.63,"profit":true},{"date":"2021-12-31","value":75.15,"profit":true},{"date":"2022-12-31","value":83.55,"profit":true},{"date":"2023-12-31","value":96.48,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 7.84B | 7.26B | 5.89B | 6.55B | 6.72B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.63,"profit":true},{"date":"2021-12-31","value":75.15,"profit":true},{"date":"2022-12-31","value":83.55,"profit":true},{"date":"2023-12-31","value":85.65,"profit":true}] |
EPS (Diluted) | 14.83 | 16.60 | 17.11 | 17.69 | 18.65 | [{"date":"2019-12-31","value":79.52,"profit":true},{"date":"2020-12-31","value":89.01,"profit":true},{"date":"2021-12-31","value":91.74,"profit":true},{"date":"2022-12-31","value":94.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
AMGN | |
---|---|
Cash Ratio | 0.44 |
Current Ratio | 1.32 |
Quick Ratio | 0.96 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
AMGN | |
---|---|
ROA (LTM) | 4.60% |
ROE (LTM) | 55.72% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
AMGN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.92 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.08 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
AMGN | |
---|---|
Trailing PE | 33.99 |
Forward PE | 12.90 |
P/S (TTM) | 4.40 |
P/B | 19.03 |
Price/FCF | 43 |
EV/R | 5.98 |
EV/Ebitda | 14.44 |
PEG | 1.91 |
Amgen Inc (AMGN) share price today is $258.78
Yes, Indians can buy shares of Amgen Inc (AMGN) on Vested. To buy Amgen Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AMGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Amgen Inc (AMGN) via the Vested app. You can start investing in Amgen Inc (AMGN) with a minimum investment of $1.
You can invest in shares of Amgen Inc (AMGN) via Vested in three simple steps:
The 52-week high price of Amgen Inc (AMGN) is $341.72. The 52-week low price of Amgen Inc (AMGN) is $255.01.
The price-to-earnings (P/E) ratio of Amgen Inc (AMGN) is 33.9923
The price-to-book (P/B) ratio of Amgen Inc (AMGN) is 19.03
The dividend yield of Amgen Inc (AMGN) is 3.57%
The market capitalization of Amgen Inc (AMGN) is $143.25B
The stock symbol (or ticker) of Amgen Inc is AMGN